Volume 14, Issue 9, Pages (September 2017)

Slides:

Advertisements

Similar presentations

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.

Advertisements

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness.

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator Mohammad-Ali.

Volume 11, Issue 2, Pages (February 2014)

Volume 14, Issue 10, Pages (October 2017)

Volume 13, Issue 1, Pages (January 2016)

Volume 11, Issue 8, Pages (August 2014)

Volume 13, Issue 11, Pages (November 2016)

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection Derek V. Exner, MD, MPH, David.

Volume 5, Issue 4, Pages (April 2008)

Volume 11, Issue 9, Pages (September 2014)

Volume 9, Issue 8, Pages (August 2012)

Volume 8, Issue 5, Pages (May 2011)

Volume 9, Issue 1, Pages (January 2012)

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Volume 6, Issue 10, Pages (October 2009)

The National ICD Registry: Now and into the future

Volume 9, Issue 8, Pages S3-S13 (August 2012)

Volume 11, Issue 1, Pages (January 2014)

Gaurav A. Upadhyay, MD, Jonathan S. Steinberg, MD Heart Rhythm

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Volume 6, Issue 12, Pages (December 2009)

Volume 11, Issue 1, Pages (January 2014)

Volume 13, Issue 3, Pages (March 2016)

Volume 13, Issue 7, Pages (July 2016)

Volume 7, Issue 1, Pages (January 2010)

Volume 15, Issue 9, Pages (September 2018)

Volume 9, Issue 5, Pages (May 2012)

Volume 11, Issue 2, Pages (February 2014)

Volume 15, Issue 10, Pages e253-e274 (October 2018)

Internal insulation breaches in an implantable cardioverter-defibrillator lead with redundant conductors Robert G. Hauser, MD, FHRS, Jay Sengupta, MD,

Volume 11, Issue 2, Pages (February 2014)

Volume 8, Issue 12, Pages (December 2011)

Erroneous shock by an AED: Importance of obtaining AED tracing to prevent inappropriate ICD implantation Brian J. Cross, MD, Mark S. Link, MD, FHRS

Volume 8, Issue 2, Pages (February 2011)

Volume 9, Issue 6, Pages (June 2012)

Ethnic and racial disparities in cardiac resynchronization therapy

Swimming pool saline chlorination units and implantable cardiac devices: A source for potentially fatal electromagnetic interference John Wight, BS,

Unusual case of late dislodgment of a superior vena cava coil

Volume 12, Issue 8, Pages (August 2015)

Anne Barnett, PA-C, Lee Eckhardt, MD, FHRS, Miguel A. Leal, MD, FHRS

Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient Isla McClelland, MD,

Volume 9, Issue 1, Pages (January 2012)

Volume 7, Issue 7, Pages (July 2010)

Volume 14, Issue 3, Pages (March 2017)

Failure of ICD therapy in lethal arrhythmogenic right ventricular cardiomyopathy type 5 caused by the TMEM43 p.Ser358Leu mutation Kasper Aalbæk Kjærgaard,

Volume 14, Issue 12, Pages (December 2017)

Volume 12, Issue 10, Pages (October 2015)

Volume 11, Issue 1, Pages (January 2014)

Volume 9, Issue 8, Pages S14-S17 (August 2012)

Volume 7, Issue 3, Pages (March 2010)

Michael R. Gold, MD, PhD, FHRS Heart Rhythm

Volume 15, Issue 1, Pages (January 2018)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator Mohammad-Ali.

Volume 11, Issue 3, Pages (March 2014)

Appropriate use of genetics in a young patient with atrioventricular block and family history of sudden cardiac death Johnni Rudbeck-Resdal, MD, Jens.

Volume 7, Issue 11, Pages (November 2010)

Daniel W. Nelson, BS, Caroline Vloka, BA, Jule Wetherbee, MD

HRS collaborates with leading medical societies to launch a voluntary laboratory accreditation program and drive quality improvement John D. Day, MD,

Volume 8, Issue 3, Pages (March 2011)

Abdominal implantable cardioverter-defibrillator placement in a patient requiring bilateral chest radiation therapy Ankur A. Karnik, MD, FHRS, CCDS,

Impact of generator replacement on the risk of Fidelis lead fracture

Serious case of the hiccups

Intermittent failure to capture: What is the mechanism?

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.

Volume 7, Issue 8, Pages (August 2010)

Orthostatic increase in defibrillation threshold leading to defibrillation failure and prolonged cardiac arrest in a sitting position: Lessons from a.

Transparent sharing of digital health data: A call to action

Volume 16, Issue 6, Pages (June 2019)

Presentation transcript:

Volume 14, Issue 9, Pages 1382-1387 (September 2017) Characterization of health care utilization in patients receiving implantable cardioverter- defibrillator therapies: An analysis of the managed ventricular pacing trial John Rickard, MD, MPH, David Whellen, MD, MPH, FHRS, Lou Sherfesee, PhD, Brett J. Peterson, BS, Tara Nahey, DVM, PhD, Anthony S. Tang, MD, FHRS, Kenneth A. Ellenbogen, MD, FHRS, Alan Cheng, MD Heart Rhythm Volume 14, Issue 9, Pages 1382-1387 (September 2017) DOI: 10.1016/j.hrthm.2017.03.040 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Annual rates for HCUs in each of the 6 periods after the implant procedure. Only HCUs relatedness to VTA, ICD therapy, heart failure, implant procedure, or the ICD system are included. HCU = health care utilization; ICD = implantable cardioverter-defibrillator; VTA = ventricular tachyarrhythmia. Heart Rhythm 2017 14, 1382-1387DOI: (10.1016/j.hrthm.2017.03.040) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Cumulative incidence rate for first VTA, VTA treated with antitachycardia pacing or shock, VTA treated with shock, VTA-related HCU, and shocked VTA-related HCU accounting for competing risk of mortality. HCU = health care utilization; VTA = ventricular tachyarrhythmia. Heart Rhythm 2017 14, 1382-1387DOI: (10.1016/j.hrthm.2017.03.040) Copyright © 2017 The Authors Terms and Conditions